Mark S. Orlando

Mark S. Orlando is a Clinical Professor of Otolaryngology at the University of Rochester School of Medicine and Dentistry (SMD). He holds advanced degrees including a Ph.D. in Audiology/Speech Pathology (University of Washington, 1990) and an M.B.A. from the Simon Graduate School of Business (2011). His work bridges clinical otolaryngology with neurodevelopmental and public health research, focusing on auditory function in infants, children, and populations exposed to environmental toxins like methylmercury.

Education:

• Ph.D., Audiology/Speech Pathol, University of Washington (1990)
• M.B.A., Simon Graduate School of Business, University of Rochester (2011)
• M.S., Medical Management, Simon Business School (2009)
• B.S., Communication Disorders, SUNY Buffalo (1984)

Research Focus: Dr. Orlando's studies investigate auditory toxicity in neonates (e.g., bilirubin-induced hearing loss), long-term outcomes of temporary conductive hearing loss in children, and the impact of environmental factors like mercury and fatty acids on auditory and neurodevelopmental health. He has contributed to universal newborn hearing screening protocols and collaborated on large-scale studies like the Seychelles Child Development Cohort.

Grants & Advising: While specific grant details are not listed, his publications reflect sustained funding for longitudinal studies. No graduate student advisees are explicitly mentioned in the provided texts.

Labs/Teams: Affiliated with pediatric and otolaryngology research groups at URMC, contributing to interdisciplinary teams studying neonatal care and environmental health impacts.